Seminars in Oncology Nursing
Volume 22, Issue 3 , Pages 144-151, August 2006

Chemotherapy and Cutaneous Toxicities: Implications for Oncology Nurses

  • Pamela Hallquist Viale

      Affiliations

    • Corresponding Author InformationAddress correspondence to Pamela Hallequist Viale, RN, MS, CS, ANP, AOCNP, 12721 Star Ridge Court, Saratoga, CA 95070-6510

Camino Medical Group, Sunnyvale, CA.

Objective

To review common cutaneous effects and dermatologic or cutaneous toxicities related to the administration of chemotherapy. These range from mostly cosmetic, such as hyperpigmentation or alopecia, to dose-limiting toxicities such as palmar-plantar erythrodysesthesia or hand-foot syndrome.

Data Sources

Current research, published literature, and internet resources.

Conclusion

Assessment and grading of associated toxicities of therapy is an integral part of caring for this patient population. Early intervention may reduce toxicities associated with therapies for this patient population

Implications for Nursing Practice

As more patients receive chemotherapy, dermatologic effects are becoming more common. Oncology nurses must be skilled in managing these side effects.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 12.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0749-2081(06)00061-1

doi:10.1016/j.soncn.2006.04.007

Seminars in Oncology Nursing
Volume 22, Issue 3 , Pages 144-151, August 2006